- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
9
0 new
High return on equity, past performance and sound balance sheet.
9 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$340.22 | 0.01% | -15.3% | US$10.4b | US$344.83 | PE25.6x | E9.6% | n/a | ||
ACAD | US$19.95 | -0.4% | -19.5% | US$3.3b | US$24.80 | PE25.8x | E25.3% | n/a | ||
PTGX | US$38.75 | 0.2% | 36.1% | US$2.3b | US$58.40 | PE8.4x | E-9.2% | n/a | ||
EXEL | US$36.85 | 5.3% | 71.2% | US$10.3b | US$36.89 | PE19.8x | E21.3% | n/a | ||
CPRX | US$21.62 | -7.1% | 54.0% | US$2.6b | US$32.22 | PE18.1x | E16.7% | n/a | ||
CORT | US$63.54 | -12.6% | 183.0% | US$6.7b | US$97.00 | PE47.4x | E38.3% | n/a | ||
BSEM | US$13.80 | -10.5% | 59.5% | US$229.8m | US$32.50 | PE14.5x | E33.8% | n/a | ||
ETST | US$0.17 | -19.0% | 118.4% | US$50.2m | n/a | PE21.7x | n/a | n/a | ||
MDXG | US$7.98 | -5.0% | -2.7% | US$1.2b | US$13.40 | PE14.8x | E-1.9% | n/a |
Page 1 of 1